Newsbenzinga
$1000 Invested In Alnylam Pharmaceuticals 20 Years Ago Would Be Worth This Much Today
· Published
Article summary
Alnylam Pharmaceuticals (NASDAQ:ALNY) has outperformed the market over the past 20 years by 5.9% on an annualized basis producing an average annual return of 15.23%. Currently, Alnylam Pharmaceuticals has a market
An excerpt from the original article.
Comments —
Loading comments…